Newton Charles W. bought KROS
March 9, 2026 · Form 4 insider transaction
Newton Charles W. bought 13,215 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,215
Price
$0.00
Total value
N/A
InsiderNewton Charles W.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 9, 2026
Filing dateMarch 11, 2026
Shares owned after13,215
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs shall vest over a three-year period in twelve equal quarterly installments with the first such vesting to occur on May 15, 2026, subject to the Reporting Person's continuous service through each such vesting date.